It does not matter how much loss they had last year even though I anticipate lower than analyst estimates. Investors care about forward year coming not past year. Past year was all just preparation for FDA submission, approval, EU submission, setting up the sales force, etc. My point is AFFYMAX has enough cash going forward the PDUFA date. Traders/shorts/MM's will try to manipulate this to the most.